445 related articles for article (PubMed ID: 26092229)
1. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.
Abdou AG; Eldien MM; Elsakka D
Int J Surg Pathol; 2015 Sep; 23(6):447-53. PubMed ID: 26092229
[TBL] [Abstract][Full Text] [Related]
2. P16INK4a Immunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran.
Ramezani M; Abdali E; Khazaei S; Vaisi-Raygani A; Sadeghi M
Asian Pac J Cancer Prev; 2016; 17(3):1093-6. PubMed ID: 27039730
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas.
Abdou AG; Maraee AH; El-Sayed EM; Elnaidany NF
Ann Diagn Pathol; 2011 Dec; 15(6):394-401. PubMed ID: 21849257
[TBL] [Abstract][Full Text] [Related]
4. Differential immunohistochemical expression of matrix metalloproteinase-10 (MMP-10) in non-melanoma skin cancers of the head and neck.
Kadeh H; Saravani S; Heydari F; Shahraki S
Pathol Res Pract; 2016 Oct; 212(10):867-871. PubMed ID: 27567711
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalization of glioma-associated oncogene homolog 1 in non melanoma skin cancer.
Bakry OA; Samaka RM; Shoeib MA; Megahed DM
Ultrastruct Pathol; 2015 Apr; 39(2):135-46. PubMed ID: 25350271
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of cytokeratin 15, cytokeratin 19, follistatin, and Bmi-1 in basal cell carcinoma.
Kim HC; Sohng SH; Shin DH; Choi JS; Bae YK
Int J Dermatol; 2016 Jan; 55(1):36-44. PubMed ID: 26739632
[TBL] [Abstract][Full Text] [Related]
7. Expression of L-type amino acid transporter 1 in various skin lesions.
Hirano K; Uno K; Kuwabara H; Kojima K; Ohno S; Sakurai H; Kamma H; Kurata A
Pathol Res Pract; 2014 Oct; 210(10):634-9. PubMed ID: 24939142
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical galectin-3 expression in non-melanoma skin cancers.
Kapucuoglu N; Basak PY; Bircan S; Sert S; Akkaya VB
Pathol Res Pract; 2009; 205(2):97-103. PubMed ID: 18951731
[TBL] [Abstract][Full Text] [Related]
9. Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin.
Stelkovics E; Kiszner G; Meggyeshazi N; Korom I; Varga E; Nemeth I; Molnar J; Marczinovits I; Krenacs T
Histol Histopathol; 2013 Jul; 28(7):941-54. PubMed ID: 23446646
[TBL] [Abstract][Full Text] [Related]
10. Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma.
Huang K; Huang C; Shan K; Chen J; Li H
Clin Exp Dermatol; 2012 Jun; 37(4):411-7. PubMed ID: 22420613
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
Gaballah MA; Ahmed RA
Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
[TBL] [Abstract][Full Text] [Related]
12. Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
de Oliveira Poswar F; de Carvalho Fraga CA; Gomes ES; Farias LC; Souza LW; Santos SH; Gomez RS; de-Paula AM; Guimarães AL
Int J Surg Pathol; 2015 Feb; 23(1):20-5. PubMed ID: 24984957
[TBL] [Abstract][Full Text] [Related]
13. Proteinase-activated receptor-2 expression in basal and squamous cell carcinomas compared with normal skin.
Dastgheib L; Monabati A; Mohammadian A; Sari-Aslani F; Marzban S; Namazi MR
J Cutan Pathol; 2009 Mar; 36(3):314-7. PubMed ID: 19032384
[TBL] [Abstract][Full Text] [Related]
14. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma.
Suiqing C; Min Z; Lirong C
J Dermatol; 2005 May; 32(5):354-60. PubMed ID: 16043897
[TBL] [Abstract][Full Text] [Related]
16. Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma.
Yu L; Galan A; McNiff JM
J Cutan Pathol; 2009 Oct; 36(10):1074-176. PubMed ID: 19187107
[TBL] [Abstract][Full Text] [Related]
17. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
18. Greater expression of TC21/R-ras2 in highly aggressive malignant skin cancer.
Lee JH; Pyon JK; Lee SH; Lee YJ; Kang SG; Kim CH; Kim DW; Nam HS; Park YH; Jeong DJ; Cho MK
Int J Dermatol; 2011 Aug; 50(8):956-60. PubMed ID: 21781067
[TBL] [Abstract][Full Text] [Related]
19. High numbers of human skin cancers express MMP2 and several integrin genes.
Orimoto AM; Neto CF; Pimentel ER; Sanches JA; Sotto MN; Akaishi E; Ruiz IR
J Cutan Pathol; 2008 Mar; 35(3):285-91. PubMed ID: 18251742
[TBL] [Abstract][Full Text] [Related]
20. Comparison of EMA,CEA, CD10 and Bcl-2 Biomarkers by Immunohistochemistry in Squamous Cell Carcinoma and Basal Cell Carcinoma of the Skin.
Ramezani M; Mohamadzaheri E; Khazaei S; Najafi F; Vaisi-Raygani A; Rahbar M; Sadeghi M
Asian Pac J Cancer Prev; 2016; 17(3):1379-83. PubMed ID: 27039776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
